Microbial transmission from mothers with obesity or diabetes to infants: an innovative opportunity to interrupt a vicious cycle
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Maternal obesity and diabetes dramatically increase the long-term risk for obesity in the next generation, and pregnancy and lactation may be critical periods at which to aim primary prevention to break the obesity cycle. It is becoming increasingly clear that the gut microbiome in newborns and infants plays a significant role in gut health and therefore child development. Alteration of the early infant gut microbiome has been correlated with the development of childhood obesity and autoimmune conditions, including asthma, allergies and, more recently, type 1 diabetes. This is likely to be due to complex interactions between mode of delivery, antibiotic use, maternal diet, components of breastfeeding and a network of regulatory events involving both the innate and adaptive immune systems within the infant host. Each of these factors are critical for informing microbiome development and can affect immune signalling, toxin release and metabolic signals, including short-chain fatty acids and bile acids, that regulate appetite, metabolism and inflammation. In several randomised controlled trials, probiotics have been administered with the aim of targeting the microbiome during pregnancy to improve maternal and infant health but the findings have often been confounded by mode of delivery, antibiotic use, ethnicity, infant sex, maternal health and length of exposure. Understanding how nutritional exposure, including breast milk, affects the assembly and development of both maternal and infant microbial communities may help to identify targeted interventions during pregnancy and in infants born to mothers with obesity or diabetes to slow the transmission of obesity risk to the next generation. The aim of this review is to discuss influences on infant microbiota colonisation and the mechanism(s) underlying how alterations due to maternal obesity and diabetes may lead to increased risk of childhood obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice
Ridaura, V. K., Faith, J. J., Rey, F. E., Cheng, J., Duncan, A. E., Kau, A. L., Griffin, N. W., Lombard, V., Henrissat, B., Bain, J. R., et al. (2013) · Science · doi:10.1126/science.1241214 · Cited by 3,788 · cited 1×
“1 for microbiota taxonomy) [14].”
Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life
Bäckhed, F., Roswall, J., Peng, Y., Feng, Q., Jia, H., Kovatcheva-Datchary, P., Li, Y., Xia, Y., Xie, H., Zhong, H., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.04.004 · Cited by 3,315
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 7×
“Data characterising intestinal microbiota in patients with type 2 diabetes showed that in addition to reduction of the Firmicutes phylum, the ratio of Bacteroidetes to Firmicutes correlated positively and significantly with plasma glucose concentration but not with BMI [61].”
InfluentialSuccession of microbial consortia in the developing infant gut microbiome
Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., Angenent, L. T., & Ley, R. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000081107 · Cited by 2,540 · cited 1×
“Cumulatively, these findings support the hypothesis that, although the early microbiome has erratic compositional shifts and high inter-individual differences before reaching a more stable microbiome at around 2 years of age [19, 20], there are clear implications for the early microbiome on life-long health.”
The Placenta Harbors a Unique Microbiome
Aagaard, K., Ma, J., Antony, K. M., Ganu, R., Petrosino, J., & Versalovic, J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008599 · Cited by 2,494 · cited 1×
“The placenta and amniotic fluid have been reported to serve as potential sources of intrauterine microbial transmission from the mother to the developing fetus [31, 32].”
Microbiota and SCFA in lean and overweight healthy subjects
Schwiertz, A., Taras, D., Schäfer, K., Beijer, S., Bos, N. A., Donus, C., & Hardt, P. D. (2010) · Obesity · doi:10.1038/oby.2009.167 · Cited by 2,457 · cited 1×
“ed in faecal samples from individuals with obesity [69], it remains to be seen whether this is a cause of or response to the metabolic and inflammatory shifts in the microbiome.”
Boney, C. M., Verma, A., Tucker, R., & Vohr, B. R. (2005) · Pediatrics · doi:10.1542/peds.2004-1808 · Cited by 2,303
Chang, P. V., Hao, L., Offermanns, S., & Medzhitov, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322269111 · Cited by 2,175 · cited 1×
“proinflammatory effectors, shifting the cells toward an anti-inflammatory phenotype [66, 68].”
Host Remodeling of the Gut Microbiome and Metabolic Changes during Pregnancy
Koren, O., Goodrich, J. K., Cullender, T. C., Spor, A., Laitinen, K., Kling Bäckhed, H., Gonzalez, A., Werner, J. J., Angenent, L. T., Knight, R., et al. (2012) · Cell · doi:10.1016/j.cell.2012.07.008 · Cited by 2,165 · cited 1×
“In 2012, Koren et al demonstrated changes in the maternal gut microbiome composition from the first to the third trimester of pregnancy [24].”
Cox, L. M., Yamanishi, S., Sohn, J., Alekseyenko, A. V., Leung, J. M., Cho, I., Kim, S. G., Li, H., Gao, Z., Mahana, D., et al. (2014) · Cell · doi:10.1016/j.cell.2014.05.052 · Cited by 1,859 · cited 1×
“Moreover, in mice, a HFD combined with maternal antibiotic use exacerbated changes in body mass and hyperinsulinaemia in the offspring, suggesting that maternal obesity may compound the effect of antibiotics on disruption of the microbiome and downstream metabolic outcomes [54].”
Antibiotics in early life alter the murine colonic microbiome and adiposity
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. (2012) · Nature · doi:10.1038/nature11400 · Cited by 1,613 · cited 1×
“tibility to allergic asthma, while the same treatment in adult mice had no effect [53–55].”
Reciprocal interactions of the intestinal microbiota and immune system
Maynard, C. L., Elson, C. O., Hatton, R. D., & Weaver, C. T. (2012) · Nature · doi:10.1038/nature11551 · Cited by 1,598 · cited 1×
“The early gut microbiome and the immune system is reviewed more comprehensively by Maynard et al [58].”
Macia, L., Tan, J., Vieira, A. T., Leach, K., Stanley, D., Luong, S., Maruya, M., Ian McKenzie, C., Hijikata, A., Wong, C., et al. (2015) · Nature Communications · doi:10.1038/ncomms7734 · Cited by 1,439 · cited 1×
“SCFAs also act as important microbial signals to remodel the intestinal microbial community through activation of the inflammasome [74], thereby helping prevent chronic intestinal inflammatory responses to microbes and their products.”
Park, J., Kim, M., Kang, S. G., Jannasch, A. H., Cooper, B., Patterson, J., & Kim, C. H. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.44 · Cited by 1,307 · cited 3×
“proinflammatory effectors, shifting the cells toward an anti-inflammatory phenotype [66, 68].”
Jumpertz, R., Le, D. S., Turnbaugh, P. J., Trinidad, C., Bogardus, C., Gordon, J. I., & Krakoff, J. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.010132 · Cited by 1,232
Temporal and spatial variation of the human microbiota during pregnancy
DiGiulio, D. B., Callahan, B. J., McMurdie, P. J., Costello, E. K., Lyell, D. J., Robaczewska, A., Sun, C. L., Goltsman, D. S. A., Wong, R. J., Shaw, G., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502875112 · Cited by 1,129 · cited 1×
“However, this pregnancy-related change in microbe composition has been challenged recently by DiGiulio et al [25] who, by repeated sampling throughout gestation, demonstrated that vaginal, gut and oral cavity microbiota remained relatively stable during and after pregnancy (except in those who experienced preterm deli…”
den Besten, G., Bleeker, A., Gerding, A., van Eunen, K., Havinga, R., van Dijk, T. H., Oosterveer, M. H., Jonker, J. W., Groen, A. K., Reijngoud, D.-J., et al. (2015) · Diabetes · doi:10.2337/db14-1213 · Cited by 1,125
Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G. G., Neyrinck, A. M., Possemiers, S., Van Holle, A., François, P., de Vos, W. M., et al. (2011) · Diabetes · doi:10.2337/db11-0227 · Cited by 1,076
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
Islam, K. B. M. S., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., Ogura, Y., Hayashi, T., & Yokota, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.046 · Cited by 918
Cabrera-Rubio, R., Collado, M. C., Laitinen, K., Salminen, S., Isolauri, E., & Mira, A. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.037382 · Cited by 886 · cited 1×
“and reduced Bifidobacterium at 6 months post delivery [44].”
Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 1×
“The beneficial effects of BA signalling via FXR and TGR5 also include attenuation of proinflammatory innate immune responses in a mouse model of NAFLD [85], lipopolysaccharide (LPS)-induced hepatic damage and inflammation [86] and inflammatory bowel disease [87].”
Santacruz, A., Collado, M. C., García-Valdés, L., Segura, M. T., Martín-Lagos, J. A., Anjos, T., Martí-Romero, M., Lopez, R. M., Florido, J., Campoy, C., et al. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510000176 · Cited by 868 · cited 1×
“in the Firmicutes phylum (Staphylococcus) as well as increases in some Proteobacteria (Escherichia coli) [21].”
Human milk glycobiome and its impact on the infant gastrointestinal microbiota
Zivkovic, A. M., German, J. B., Lebrilla, C. B., & Mills, D. A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000083107 · Cited by 679 · cited 1×
“Human milk glycans are a large and diverse group of polysaccharides that include free human milk oligosaccharides (HMOs), glycoproteins, glycopeptides and glycolipids capable of enriching populations of Bifidobacteria [39].”
Cardwell, C. R., Stene, L. C., Joner, G., Cinek, O., Svensson, J., Goldacre, M. J., Parslow, R. C., Pozzilli, P., Brigis, G., Stoyanov, D., et al. (2008) · Diabetologia · doi:10.1007/s00125-008-0941-z · Cited by 590 · cited 1×
“46% increase in obesity risk at 7 years of age [29] and a 20% increased risk in development of type 1 diabetes compared with children born vaginally [30].”
DeSisto, C. L., Kim, S. Y., & Sharma, A. J. (2014) · Preventing Chronic Disease · doi:10.5888/pcd11.130415 · Cited by 577 · cited 3×
“BA Bile acid FXR Farnesoid X receptor GDM Gestational diabetes mellitus GPR G protein-coupled receptor GWG Gestational weight gain * Jacob E. Friedman jed.friedman@ucdenver.edu 1 Department of Pediatrics, Section of Neonatology, University of Colorado School ofMedicine, AnschutzMedical Campus,Mail Stop 8106, 12801 Eas…”
InfluentialAjslev, T. A., Andersen, C. S., Gamborg, M., Sørensen, T. I. A., & Jess, T. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.27 · Cited by 534 · cited 1×
“Studies of infant postnatal antibiotic exposure in the first 6–12 months of life have found an association between antibiotic use and elevated weight and central adiposity as early as 24 months and up to 9 years of age regardless of maternal weight status [52, 56, 57].”
Buckley, B. S., Harreiter, J., Damm, P., Corcoy, R., Chico, A., Simmons, D., Vellinga, A., Dunne, F., & on behalf of the DALI Core Investigator Group (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03541.x · Cited by 360
Infant antibiotic exposure and the development of childhood overweight and central adiposity
Azad, M. B., Bridgman, S. L., Becker, A. B., & Kozyrskyj, A. L. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.119 · Cited by 331 · cited 2×
“Retrospective studies of antibiotic exposure at various windows of time during the first 2 years of life found that broad-spectrum treatment is associatedwith childhood obesity [51, 52].”
Oben, J. A., Mouralidarane, A., Samuelsson, A.-M., Matthews, P. J., Morgan, M. L., Mckee, C., Soeda, J., Fernandez-Twinn, D. S., Martin-Gronert, M. S., Ozanne, S. E., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.042 · Cited by 314 · cited 1×
“increased body weight, plasma insulin and proinflammatory cytokines in offspring [37].”
Roger, L. C., Costabile, A., Holland, D. T., Hoyles, L., & McCartney, A. L. (2010) · Microbiology · doi:10.1099/mic.0.043224-0 · Cited by 291 · cited 1×
“Compared with breastfed infants, the diversity of the genus Bifidobacterium was found to be decreased in formula-fed infants [50] and this was associated with increased adiposity at 18 months [27].”
McMahan, R. H., Wang, X. X., Cheng, L. L., Krisko, T., Smith, M., El Kasmi, K., Pruzanski, M., Adorini, L., Golden-Mason, L., Levi, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.446575 · Cited by 225 · cited 7×
“Maternal Western-style diet (WSD) and insulin resistance in non-human primates (NHPs) promote lipotoxicity in the fetal liver [7] and NAFLDlike changes that persist in the offspring despite weaning to a healthy diet [8].”
InfluentialWright, D. P., Rosendale, D. I., & Roberton, A. M. (2000) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2000.tb09265.x · Cited by 185 · cited 1×
“A role for Prevotella in mucin degradation in the gut [63] suggests that changes in gut health”
Ilmonen, J., Isolauri, E., Poussa, T., & Laitinen, K. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2010.09.009 · Cited by 144
Fugmann, M., Breier, M., Rottenkolber, M., Banning, F., Ferrari, U., Sacco, V., Grallert, H., Parhofer, K. G., Seissler, J., Clavel, T., et al. (2015) · Scientific Reports · doi:10.1038/srep13212 · Cited by 131
Boyle, K. E., Patinkin, Z. W., Shapiro, A. L. B., Baker, P. R., Dabelea, D., & Friedman, J. E. (2016) · Diabetes · doi:10.2337/db15-0849 · Cited by 115
Self-citation
Cited by
The prenatal gut microbiome: are we colonized with bacteria in utero ?
Walker, R. W., Clemente, J. C., Peter, I., & Loos, R. J. F. (2017) · Pediatric Obesity · doi:10.1111/ijpo.12217 · Cited by 293
Ferrocino, I., Ponzo, V., Gambino, R., Zarovska, A., Leone, F., Monzeglio, C., Goitre, I., Rosato, R., Romano, A., Grassi, G., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30735-9 · Cited by 255
Short-Chain Fatty Acids, Maternal Microbiota and Metabolism in Pregnancy
Ziętek, M., Celewicz, Z., & Szczuko, M. (2021) · Nutrients · doi:10.3390/nu13041244 · Cited by 233
“It is possible that human intestinal microflora play a role in the regulation of nutrient metabolism, and dysbiosis may be associated with an increased acquisition of energy resources [74].”
BackgroundReappraisal of probiotics’ safety in human
Sotoudegan, F., Daniali, M., Hassani, S., Nikfar, S., & Abdollahi, M. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.032 · Cited by 154
Röytiö, H., Mokkala, K., Vahlberg, T., & Laitinen, K. (2017) · British Journal Of Nutrition · doi:10.1017/s0007114517002100 · Cited by 128
Metadata
- Authors
- Soderborg, T. K., Borengasser, S. J., Barbour, L. A., & Friedman, J. E.
- Venue
- Diabetologia
- Published
- 2016-02-02
- Volume
- 59
- Issue
- 5
- Pages
- 895-906
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2255195647
- Cited by
- 83
- References
- 35
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.